Imaoka等［7］认为，在可以切除的肝癌患者手术前采用HACE或选择性门静脉栓塞（selective embolization of portal vein, SEPV）［8］有助于预防术后复发。但多数 人持反对意见［9］。
基于3个网页-相关网页
Objective to determine the possibility of two-stage hepatectomy for primary hepatocellular carcinoma (HCC) after preoperative selective portal vein embolization (POSPVE).
目的探讨术前选择性门静脉栓塞(POSPVE)后不能手术切除的原发性肝癌(HCC)二期切除的可能性。
Objective To evaluate the safety and efficacy of selective portal vein embolization (SPVE) with ZT glue in rabbit.
目的探讨ZT胶行兔选择性门静脉栓塞(SPVE)的安全性及有效性。
Objective: Researching the effect of applying selective portal vein embolization (SPVE) in the primary hepatic carcinoma patients.
目的探讨晚期肝门部胆管癌患者经皮经肝门静脉栓塞术的护理。
应用推荐